A Study of EDP-235 in Healthy Subjects

NCT05246878 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS CoV 2 Infection

Interventions

DRUG: EDP-235
DRUG: Placebo

Sponsor

Enanta Pharmaceuticals, Inc